ELAN vs JAZZ: stock comparison and AI forecast
Elanco Animal Health Inc (ELAN) and Jazz Pharmaceuticals Plc (JAZZ) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ELAN Elanco Animal Health Inc
- Price
- $24.10 +7.1% · 6M
- Market Cap
- $12.04B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
JAZZ Jazz Pharmaceuticals Plc
- Price
- $214.44 +3.1% · 6M
- Market Cap
- $13.92B
- P/E Ratio
- 70.8x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- JAZZ is 1.2 times larger than ELAN by market capitalization ($13.92B against $12.04B).
- Over the last six months ELAN returned +7.1% and JAZZ +3.1%.
- JAZZ turns 4.4% of its revenue into net income, against -4.0% for ELAN.
- JAZZ carries 1.86 times debt per unit of equity, against 1.06 times for ELAN.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ELAN | JAZZ |
|---|---|---|
| Market Cap | $12.04B | $13.92B |
| P/E Ratio | – | 70.78x |
| P/B Ratio | 1.83x | 3.32x |
| EPS | $-0.38 | $3.03 |
| Book Value/Share | $13.19 | $64.57 |
| Revenue/Share | $10.05 | $72.68 |
| FCF/Share | $0.76 | $24.98 |
Profitability & Margins
| Metric | ELAN | JAZZ |
|---|---|---|
| ROE | -3.0% | 4.9% |
| ROA | -1.5% | 1.7% |
| ROIC | – | 4.5% |
| Gross Margin | 55.4% | – |
| Operating Margin | – | 9.0% |
| Net Margin | -4.0% | 4.4% |
| EBT Margin | -3.3% | 3.2% |
| Tax Rate | -19.9% | 36.0% |
Financial Health
| Metric | ELAN | JAZZ |
|---|---|---|
| Current Ratio | 2.05x | 1.82x |
| Quick Ratio | 1.10x | 1.64x |
| D/E Ratio | 1.06x | 1.86x |
| Financial Leverage | 2.06x | 2.86x |
| Interest Coverage | – | 1.0x |
| Working Capital | $1.95B | $2.08B |
Cash Flow
| Metric | ELAN | JAZZ |
|---|---|---|
| Operating Cash Flow | $617M | $1.69B |
| Free Cash Flow | $379M | $1.62B |
| Capital Spending | -$238M | -$71M |
| OCF Growth YoY | 7.9% | 21.6% |
| FCF Growth YoY | 5.0% | 21.3% |
| FCF/Sales | 7.5% | 34.4% |
| CapEx/Sales | 4.7% | 1.5% |
Operational Efficiency
| Metric | ELAN | JAZZ |
|---|---|---|
| Asset Turnover | 0.37x | 0.39x |
| Receivables Turnover | 4.7x | 5.4x |
| Inventory Turnover | 1.3x | – |
| Fixed Assets Turnover | 3.6x | 21.0x |
| Days Sales Outstanding | 78 days | 68 days |
| Days Inventory | 288 days | – |
| Payables Period | 70 days | – |
| Cash Conversion Cycle | 297 days | – |
Income Statement
| Metric | ELAN | JAZZ |
|---|---|---|
| Total Revenue | $5.02B | $4.72B |
| Operating Income | – | $426M |
| Net Income | -$199M | $206M |
| R&D Expense | $371M | $829M |
| SG&A Expense | $1.52B | $1.56B |
| Cost of Goods Sold | $2.24B | – |
Dividend & Shareholder Information
| Metric | ELAN | JAZZ |
|---|---|---|
| Shares Outstanding | 500M | 65M |
| Net Income Growth | -145.8% | – |
| EPS Growth | -147.5% | – |
ELAN vs JAZZ: stock comparison and AI forecast
Which is bigger, ELAN or JAZZ?
JAZZ is 1.2 times larger than ELAN by market capitalization ($13.92B against $12.04B).
Which stock performed better over the last six months, ELAN or JAZZ?
Over the last six months ELAN returned +7.1% and JAZZ +3.1%.
Which one does Intratio's AI model rank higher, ELAN or JAZZ?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.